Evidence map›Paper›PMID 31932744›Full record

ArticleThe Journal of antibiotics2020

Synthesis of water-soluble prodrugs of 5-modified 2'-deoxyuridines and their antibacterial activity.

Sergey D Negrya, Maxim V Jasko, Pavel N Solyev, Inna L Karpenko, Olga V Efremenkova, Byazilya F Vasilyeva, Irina G Sumarukova, Sergey N Kochetkov, Liudmila A Alexandrova

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of antibiotics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. New Biocides Based onInternational journal of molecular sciences · 2024
    Article
  3. Design and Synthesis of Novel Antimicrobial Agents.Antibiotics (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Article
  6. Antibacterial Prodrugs to Overcome Bacterial Resistance.Molecules (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sergey D NegryaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 32 Vavilova St., 119991, Moscow, Russia.
Maxim V JaskoEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 32 Vavilova St., 119991, Moscow, Russia.
Pavel N SolyevEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 32 Vavilova St., 119991, Moscow, Russia.ORCID http://orcid.org/0000-0002-5546-4975
Inna L KarpenkoEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 32 Vavilova St., 119991, Moscow, Russia.
Olga V EfremenkovaGause Institute of New Antibiotics, 11 Bolshaya Pirogovskaya St., 119021, Moscow, Russia.
Byazilya F VasilyevaGause Institute of New Antibiotics, 11 Bolshaya Pirogovskaya St., 119021, Moscow, Russia.
Irina G SumarukovaGause Institute of New Antibiotics, 11 Bolshaya Pirogovskaya St., 119021, Moscow, Russia.ORCID http://orcid.org/0000-0001-7750-7983
Sergey N KochetkovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 32 Vavilova St., 119991, Moscow, Russia.
Liudmila A AlexandrovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 32 Vavilova St., 119991, Moscow, Russia. ala2004_07@mail.ru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently we have synthesized a set of pyrimidine nucleoside derivatives bearing extended alkyltriazolylmethyl substituents at position 5 of the nucleic base, and showed their significant activity against Mycobacterium tuberculosis virulent laboratory strain H37Rv as well as drug-resistant MS-115 strain. The presence of a lengthy hydrophobic substituent leads to the reduction of nucleoside water solubility making their antibacterial activity troublesome to study. A series of water-soluble forms of 5-modified 2'-deoxyuridines 4a-c and 8a-c were synthesized. They appeared at least two orders more soluble compared with the parent compounds 1a and 1b. Their half-hydrolysis time was 5-12 h, which can be considered optimal for prodrugs used in clinics. Obtained compounds showed moderate activity (MIC 48-95 µg·ml

Indexed as

Anti-Bacterial AgentsCell LineDeoxyuridineGram-Positive BacteriaHumansHydrophobic and Hydrophilic InteractionsMicrobial Sensitivity TestsProdrugsSolubilityStructure-Activity RelationshipWaterAnti-Bacterial AgentsDeoxyuridineProdrugsWater

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.